 |
|
|
| |
Durable Efficacy of Two-Drug Regimen of DTG + 3TC in Antiretroviral Treatment-Naive Adults With HIV-1 Infection at 96 Weeks: Subgroup Analyses in the GEMINI Studies
|
| |
| |
ID Week Oct 2-6 Wash DC 201
Reported by Jules Levin
Jean van Wyk,1 Choy Man,2 Jörg Sievers,1 Rimgaile Urbaityte,3 Mark Underwood,2
Allan Tenorio,2 Keith Pappa,2 Brian Wynne,2 Kimberly Smith,2 Martin Gartland2
1ViiV Healthcare, Brentford, United Kingdom; 2ViiV Healthcare, Research Triangle Park, NC, United States; 3GlaxoSmithKline, Stockley Park, United Kingdom
|
| |
|
|
|
|
|
